Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 13,186 shares at $17.81 ($238K) on 2025-04-07, disclosed to the SEC on 2025-04-09.
Scheduled sale ($238k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.81 | 3,756 | $67K | 28.1% |
| 2 | $17.81 | 3,756 | $67K | 28.1% |
| 3 | $18.29 | 2,763 | $51K | 21.3% |
| 4 | $18.29 | 2,763 | $51K | 21.3% |
| 5 | $19.27 | 148 | $3K | 1.2% |
| Total | $18.03 avg | 13,186 |
| $238K |
| 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |